Neuroradiology: Page 235

Alzheimer's disease, Part I: PET yields surprising findings in hippocampus

By Eric Barnes

Predicting who will get Alzheimer's disease is an important question that nuclear medicine is beginning to answer. In Part I of our series on AD, researchers from UCLA find an unexpected link between perceived cognitive decline and reduced FDG metabolism in the hippocampus.

September 6, 2001

4-D Neuroimaging opens first Magnes site

By AuntMinnie.com staff writers

Magnetic source imaging developer 4-D Neuroimaging's first Magnes 3600 system has opened for operation at the Veterans Administration Medical Center in Minneapolis, MN.

August 26, 2001

SPECT has a good ear for cochlear implants

By Eric Barnes

Imaging of cochlear implant candidates has generally been limited to CT and MRI evaluations of the temporal bone. But researchers in Texas are using SPECT to study brain activation in response to sound stimuli. They want to pick the side with the best chance of success.

August 15, 2001

PET reveals relapse potential for women with eating disorders

By Jennifer Lung

Psychiatrists from the University of Pittsburgh School of Medicine used PET to measure serotonin binding in the brains of healthy and bulimic women.

July 19, 2001

Nycomed Amersham, Neurochem to collaborate on Alzheimer's agents

By AuntMinnie.com staff writers

Contrast developer Nycomed Amersham Imaging has signed an agreement with Canadian pharmaceutical firm Neurochem that could result in new products for detecting early signs of Alzheimer's disease.

July 18, 2001

CMS deals blow to gamma camera PET

By AuntMinnie.com staff writers

The U.S. agency that administers the Medicare and Medicaid programs has ruled out reimbursement for most PET studies conducted on gamma cameras rather than dedicated PET systems. The ruling is a blow to nuclear medicine advocates, who had hoped that the agency would adopt a more liberal standard when paying for PET exams.

July 9, 2001

MDS Nordion to build new cyclotron

By AuntMinnie.com staff writers

Canadian radioisotope producer MDS Nordion is planning to spend $20 million to build a new cyclotron to produce medical radioisotopes. The cyclotron will produce iodine-123 and palladium-103, and will be located at a MDS Nordion facility in Vancouver.

July 8, 2001

Wagner taps PET Alzheimer’s study as SNM 2001’s Image of the Year

By Brian Casey

TORONTO - A PET study of a new radiopharmaceutical developed for imaging the early onset of Alzheimer’s disease was named Image of the Year by Dr. Henry Wagner Monday at the Society of Nuclear Medicine meeting.

June 25, 2001

PET predicts future cognitive decline

By Eric Barnes

TORONTO - In an effort to assess the prognostic value of FDG-PET in people with mild symptoms of memory loss, investigators from UCLA sought to correlate cerebral PET results with future cognitive decline. In a study presented Monday, PET predicted which cognitively impaired patients could be expected to worsen.

June 25, 2001

MRI flies high for detection of neurological jet lag markers

By Jennifer Lung

This is your brain on jet lag. According to a study at the University of Bristol in the U.K., frequent exposure to jet lag can cause a reduction of the right temporal lobe volume, higher cortisol levels, and impaired cognitive performance.

June 20, 2001

Odin Medical introduces intraoperative MR system for neurosurgery

By Kate Madden Yee

A new company, Odin Medical Technologies, has developed what it believes is the next step in applying MR technology to surgical procedures. The product, PoleStar N-10, is a compact, semi-portable, open system designed specifically for use in brain surgery.

May 30, 2001

Unified imaging and surgical approach streamlines brain tumor treatment

By Shalmali Pal

A vacuum dental cast could be the key to performing the ultimate hat trick in brain tumor treatment, providing a way to fuse multimodality images, guide neurosurgery, and target radiation therapy.

May 13, 2001

Previous Page

Page 235 of 239

Next Page